Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Anti-EGFR Agents: Current Status, Forecasts and Future Directions.
Target Oncol. 2016 Dec;11(6):739-752. doi: 10.1007/s11523-016-0456-3.
Target Oncol. 2016.
PMID: 27515815
Review.
Novel engineered TRAIL-based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance.
Rozga P, Kloska D, Pawlak S, Teska-Kaminska M, Galazka M, Bukato K, Pieczykolan A, Jaworski A, Molga-Kaczmarska A, Kopacz A, Badyra B, Kachamakova-Trojanowska N, Zolnierkiewicz O, Targosz-Korecka M, Poleszak K, Szymanik M, Zerek B, Pieczykolan J, Jozkowicz A, Grochot-Przeczek A.
Rozga P, et al.
Int J Cancer. 2020 Aug 15;147(4):1117-1130. doi: 10.1002/ijc.32845. Epub 2020 Jan 24.
Int J Cancer. 2020.
PMID: 31863596
Free article.
Item in Clipboard
AD-O53.2--a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L.
Pieczykolan JS, Kubiński K, Masłyk M, Pawlak SD, Pieczykolan A, Rózga PK, Szymanik M, Gałązka M, Teska-Kamińska M, Żerek B, Bukato K, Poleszak K, Jaworski A, Strożek W, Świder R, Zieliński R.
Pieczykolan JS, et al. Among authors: pawlak sd.
Invest New Drugs. 2014 Dec;32(6):1155-66. doi: 10.1007/s10637-014-0153-y. Epub 2014 Sep 4.
Invest New Drugs. 2014.
PMID: 25182378
Item in Clipboard
Improved cytotoxicity of novel TRAIL variants produced as recombinant fusion proteins.
Figiel M, Bonarek P, Górecki A, Pawlak SD, Zerek B, Checinska B, Pieczykolan J, Dziedzicka-Wasylewska M.
Figiel M, et al. Among authors: pawlak sd.
Protein Eng Des Sel. 2018 Feb 1;31(2):37-46. doi: 10.1093/protein/gzx065.
Protein Eng Des Sel. 2018.
PMID: 29361050
Item in Clipboard
A theoretical model of restriction endonuclease NlaIV in complex with DNA, predicted by fold recognition and validated by site-directed mutagenesis and circular dichroism spectroscopy.
Chmiel AA, Radlinska M, Pawlak SD, Krowarsch D, Bujnicki JM, Skowronek KJ.
Chmiel AA, et al. Among authors: pawlak sd.
Protein Eng Des Sel. 2005 Apr;18(4):181-9. doi: 10.1093/protein/gzi019. Epub 2005 Apr 22.
Protein Eng Des Sel. 2005.
PMID: 15849215
Item in Clipboard
Inference of relationships in the 'twilight zone' of homology using a combination of bioinformatics and site-directed mutagenesis: a case study of restriction endonucleases Bsp6I and PvuII.
Pawlak SD, Radlinska M, Chmiel AA, Bujnicki JM, Skowronek KJ.
Pawlak SD, et al.
Nucleic Acids Res. 2005 Jan 31;33(2):661-71. doi: 10.1093/nar/gki213. Print 2005.
Nucleic Acids Res. 2005.
PMID: 15684412
Free PMC article.
Item in Clipboard
Human ATP-dependent RNA/DNA helicase hSuv3p interacts with the cofactor of survivin HBXIP.
Minczuk M, Mroczek S, Pawlak SD, Stepien PP.
Minczuk M, et al. Among authors: pawlak sd.
FEBS J. 2005 Oct;272(19):5008-19. doi: 10.1111/j.1742-4658.2005.04910.x.
FEBS J. 2005.
PMID: 16176273
Free article.
Item in Clipboard
Cite
Cite